4//SEC Filing
Lung Therapeutics, Inc. 4
Accession 0001213900-20-041606
CIK 0001733413other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 4:31 PM ET
Size
7.5 KB
Accession
0001213900-20-041606
Insider Transaction Report
Form 4
Lung Therapeutics, Inc.
10% Owner
Transactions
- Sale
Common Stock
2020-12-04$13.86/sh−250,000$3,465,000→ 2,950,000 total - Sale
Common Stock
2020-12-04$13.85/sh−500,000$6,925,000→ 3,500,000 total - Sale
Common Stock
2020-12-04$13.86/sh−300,000$4,158,000→ 3,200,000 total
Documents
Issuer
TFF Pharmaceuticals, Inc.
CIK 0001733413
Entity typeother
IncorporatedTX
Related Parties
1- filerCIK 0001611241
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 4:31 PM ET
- Size
- 7.5 KB